Tram Anh Wartel

Title: Tram Anh Wartel: Innovator in Dengue Vaccination

Introduction

Tram Anh Wartel is a notable inventor based in Singapore, recognized for his contributions to the field of vaccine development. His innovative work focuses on enhancing booster vaccination methods against dengue virus, a significant public health concern in tropical regions.

Latest Patents

Wartel holds a patent for "Compositions for booster vaccination against dengue." This invention is directed to a method of booster vaccination and a vaccine composition designed to induce a neutralizing antibody response in individuals who have previously received primary vaccinations against all four serotypes of the dengue virus. The composition includes a dengue antigen from at least one of the serotypes or a nucleic acid construct capable of expressing these antigens. The booster vaccination aims to achieve a two-fold increase in the neutralizing antibody titre against each serotype.

Career Highlights

Tram Anh Wartel is currently associated with Sanofi Pasteur Inc., a leading company in vaccine development. His work at Sanofi Pasteur has been pivotal in advancing the understanding and treatment of dengue fever through innovative vaccination strategies.

Collaborations

Wartel collaborates with talented professionals in his field, including Diana Coronel and Betzana Zambrano. These collaborations enhance the research and development efforts aimed at improving vaccine efficacy and safety.

Conclusion

Tram Anh Wartel's contributions to dengue vaccination represent a significant advancement in public health. His innovative approach to booster vaccinations is crucial in the fight against dengue virus, showcasing the importance of continued research and development in vaccine technology.